CN105661210A - 一种混合味西柚汁 - Google Patents
一种混合味西柚汁 Download PDFInfo
- Publication number
- CN105661210A CN105661210A CN201610174489.3A CN201610174489A CN105661210A CN 105661210 A CN105661210 A CN 105661210A CN 201610174489 A CN201610174489 A CN 201610174489A CN 105661210 A CN105661210 A CN 105661210A
- Authority
- CN
- China
- Prior art keywords
- parts
- grapefruit juice
- juice
- flavored
- mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015201 grapefruit juice Nutrition 0.000 title claims abstract description 32
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 27
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000011573 trace mineral Substances 0.000 claims abstract description 9
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 9
- 239000000230 xanthan gum Substances 0.000 claims abstract description 9
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 9
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 9
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 9
- 235000012907 honey Nutrition 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000010025 steaming Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 8
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 3
- 239000000654 additive Substances 0.000 abstract description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 239000000049 pigment Substances 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 206010011224 Cough Diseases 0.000 abstract description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 208000029078 coronary artery disease Diseases 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 201000001421 hyperglycemia Diseases 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 239000003755 preservative agent Substances 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 238000010791 quenching Methods 0.000 abstract description 2
- 230000000171 quenching effect Effects 0.000 abstract description 2
- 230000035922 thirst Effects 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 230000002087 whitening effect Effects 0.000 abstract description 2
- 244000298697 Actinidia deliciosa Species 0.000 abstract 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 10
- 230000006872 improvement Effects 0.000 description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 229960000304 folic acid Drugs 0.000 description 5
- 235000019152 folic acid Nutrition 0.000 description 5
- 239000011724 folic acid Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 208000019622 heart disease Diseases 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 101100129915 Escherichia coli (strain K12) melB gene Proteins 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000004218 vascular function Effects 0.000 description 2
- 208000009206 Abruptio Placentae Diseases 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000001362 Fetal Growth Retardation Diseases 0.000 description 1
- 206010070531 Foetal growth restriction Diseases 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 1
- 206010070538 Gestational hypertension Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000030941 fetal growth restriction Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 208000018773 low birth weight Diseases 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 201000008532 placental abruption Diseases 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种混合味西柚汁由以下重量百分比的组分组成:西柚汁57-60份,猕猴桃汁10-20份,水10-20份,蜂蜜3-5份,枸杞子2-3份,红糖1-2份,柠檬酸0.2-0.3份,黄原胶0.2-0.5份,微量元素0.3-0.5份。本发明改变了传统单一果汁加工的配方,制备的的混合味西柚汁营养更合理、全面;具有祛痰镇咳、抗菌抗病毒等作用;对高血压、高血脂、高血糖、冠心病都有一定的辅助治疗作用;促进人体正常的新陈代谢;在解渴的同时具有降低血脂和降低胆固醇的效果,可以排毒养颜,美白皮肤,还可以防止动脉硬化等疾病;没有任何防腐蚀、色素以及其他添加剂,安全健康无污染,对消费者身体无任何副作用,消费者可以长期放心饮用。
Description
技术领域
本发明涉及一种食品领域,具体涉及一种混合味西柚汁。
背景技术
西柚含有丰富的果胶成分,可降低低密度脂蛋白胆固醇的含量,减轻动脉血管壁的损伤,维护血管功能,预防心脏病。并且集柚子和甜橙优点于一身,凭借其很高的营养价值,深受广大消费者的推崇。西柚中还含有天然叶酸。西柚是少有的富含钾而几乎不含钠的水果,因此是高血压、心脏病及肾脏病患者的最佳食疗水果。
现在人们喜欢饮用西柚汁而不是直接食用西柚,因此目前市场上西柚汁的需求量巨大。然而目前市场中一些西柚汁大都含有防腐剂、色素、添加剂等等,长期饮用,有害身体健康。
发明内容
本发明的目的是为了克服以上的不足而提供的一种纯天然混合味西柚汁,它具有营养丰富、含有天然叶酸、降低胆固醇、维护心血管、促进心脏保护、促消化、健脑镇静等作用,是一款天然保健饮品。能达到效果显著,口感好,饮用方便,安全无毒副作用的目的。
西柚含有丰富的果胶成分,可降低低密度脂蛋白胆固醇的含量,减轻动脉血管壁的损伤,维护血管功能,预防心脏病。并且集柚子和甜橙优点于一身,凭借其很高的营养价值,深受广大消费者的推崇。西柚中还含有天然叶酸。叶酸不但对早期妊娠非常重要,在整个怀孕期也同样必不可少。孕期随着胎儿身体组织迅速成长,孕妇需要大量叶酸来满足胎儿的需要。叶酸缺乏不仅会使妊娠高血压症、胎盘早剥的发生率增高,更会导致孕妇患上巨幼红细胞贫血,出现胎儿宫内发育迟缓、早产及新生儿低出生体重。因此,西柚也是孕期妇女首选的水果。高血压患者常服用降压药,以排除体内多余的钠,维持身体正常的生化代谢平衡,但同时往往又使体内必需的钾流失。而钾元素对于维护心脏、血管、肾脏的功能,是非常重要的。研究发现,当人体过多地摄取高脂肪、高热量营养过剩,血脂增高,大量脂质尤其是低密度脂蛋白黏附于动脉血管内壁,引起动脉硬化,导致心、脑、肾等重要脏器供血不足,引起心脏病或大脑及肾病等病变。西柚是少有的富含钾而几乎不含钠的水果,因此是高血压、心脏病及肾脏病患者的最佳食疗水果。
猕猴桃中有良好的膳食纤维,它不仅能降低胆固醇,促进心脏健康,而且可以帮助消化,防止便秘,快速清除并预防体内堆积的有害代谢物。猕猴桃中富含的维生素C作为一种抗氧化剂,能够有效抑制这种硝化反应,防止癌症发生。猕猴桃中含有的血清促进素具有稳定情绪、镇静心情的作用,另外它所含的天然肌醇,有助于脑部活动,因此能帮助忧郁之人走出情绪低谷。
枸杞子含有丰富的胡萝卜素、多种维生素和钙、铁等健康眼睛的必需营养物质。
本发明的技术方案包括:一种混合味西柚汁,由以下重量百分比的组分组成:西柚汁57-60份,猕猴桃汁10-20份,水10-20份,蜂蜜3-5份,枸杞子2-3份,红糖1-2份,柠檬酸0.2-0.3份,黄原胶0.2-0.5份,微量元素0.3-0.5份。
本发明的进一步改进在于:西柚汁是由西柚榨取。
本发明的进一步改进在于:猕猴桃汁是由新鲜猕猴桃榨取出来的纯猕猴桃汁。
本发明的进一步改进在于:将蜂蜜、枸杞子、红糖加入水中蒸煮10-15min,冷却后将其浆汁用4层纱布过滤。
本发明的进一步改进在于:水,特指纯净水。
本发明的进一步改进在于:蜂蜜是洋槐蜂蜜。
本发明的有益效果:本发明改变了传统单一果汁加工的配方,制备的的混合味西柚汁营养更合理、全面;具有祛痰镇咳、抗菌抗病毒等作用;对高血压、高血脂、高血糖、冠心病都有一定的辅助治疗作用;促进人体正常的新陈代谢;在解渴的同时具有降低血脂和降低胆固醇的效果,可以排毒养颜,美白皮肤,还可以防止动脉硬化等疾病;没有任何防腐蚀、色素以及其他添加剂,安全健康无污染,对消费者身体无任何副作用,消费者可以长期放心饮用。
具体实施方式:
为了加深对本发明的理解,下面将结合实施例对本发明作进一步详述,该实施例仅用于解释本发明,并不构成对本发明保护范围的限定。
实施例一
由以下重量百分比的组分组成:西柚汁57份,猕猴桃汁15份,水12份,蜂蜜3份,枸杞子2份,红糖1份,柠檬酸0.3份,黄原胶0.2份,微量元素0.3份。
实施例二
由以下重量百分比的组分组成:西柚汁58份,猕猴桃汁12份,水10份,蜂蜜4份,枸杞子3份,红糖2份,柠檬酸0.2份,黄原胶0.3份,微量元素0.5份。
实施例三
由以下重量百分比的组分组成:西柚汁60份,猕猴桃汁10份,水15份,蜂蜜5份,枸杞子2.7份,红糖1.5份,柠檬酸0.3份,黄原胶0.5份,微量元素0.4份。
实施例四
由以下重量百分比的组分组成:西柚汁59份,猕猴桃汁16份,水16份,蜂蜜5份,枸杞子2.4份,红糖1.5份,柠檬酸0.3份,黄原胶0.2份,微量元素0.5份。
实施例五
由以下重量百分比的组分组成:西柚汁57份,猕猴桃汁20份,水20份,蜂蜜4份,枸杞子2份,红糖1份,柠檬酸0.2份,黄原胶0.4份,微量元素0.4份。
实施例六
由以下重量百分比的组分组成:西柚汁59份,猕猴桃汁18份,水18份,蜂蜜3份,枸杞子3份,红糖2份,柠檬酸0.2份,黄原胶0.3份,微量元素0.3份。
根据以上实施例得出实验检测数据如下:
营养成分
根据上述数据显示可以看出,本发明的一种混合味西柚汁营养成分多,含量高;均和营养,抑制挑食,增强抵抗力;老少皆宜、适口性强,适合长期饮用,是居家旅行的首选;存储时间长,便于运输。
以上所述仅为说明本发明的实施方式,并不用于限制本发明,对于本领域的技术人员来说,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (6)
1.一种混合味西柚汁,其特征在于:由以下重量百分比的组分组成:西柚汁57-60份,猕猴桃汁10-20份,水10-20份,蜂蜜3-5份,枸杞子2-3份,红糖1-2份,柠檬酸0.2-0.3份,黄原胶0.2-0.5份,微量元素0.3-0.5份。
2.根据权利要求1所述的一种混合味西柚汁,其特征在于:西柚汁是由西柚榨取。
3.根据权利要求2所述的一种混合味西柚汁,其特征在于:猕猴桃汁是由新鲜猕猴桃榨取出来的纯猕猴桃汁。
4.根据权利要求3所述的一种混合味西柚汁,其特征在于:将蜂蜜、枸杞子、红糖加入水中蒸煮10-15min,冷却后将其浆汁用4层纱布过滤。
5.根据权利要求4所述的一种混合味西柚汁,其特征在于:水,特指纯净水。
6.根据权利要求5所述的一种混合味西柚汁,其特征在于:蜂蜜是洋槐蜂蜜。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610174489.3A CN105661210A (zh) | 2016-03-25 | 2016-03-25 | 一种混合味西柚汁 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610174489.3A CN105661210A (zh) | 2016-03-25 | 2016-03-25 | 一种混合味西柚汁 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105661210A true CN105661210A (zh) | 2016-06-15 |
Family
ID=56215361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610174489.3A Pending CN105661210A (zh) | 2016-03-25 | 2016-03-25 | 一种混合味西柚汁 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105661210A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115119911A (zh) * | 2022-06-06 | 2022-09-30 | 河南英的食品有限公司 | 一种含红西柚的复合果汁及加工方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101467755A (zh) * | 2007-12-27 | 2009-07-01 | 天津市中英保健食品有限公司 | 浓缩天然西柚汁 |
CN102440414A (zh) * | 2010-10-13 | 2012-05-09 | 段英侠 | 一种蜂蜜柚子汁 |
CN103099260A (zh) * | 2011-11-11 | 2013-05-15 | 威海金琳水产有限公司 | 桑葚葡萄柚混合饮料及制作方法 |
CN103844291A (zh) * | 2012-11-30 | 2014-06-11 | 邓耀林 | 沙田柚汁及其制备方法 |
CN103932324A (zh) * | 2014-04-04 | 2014-07-23 | 郎溪县侯村大千生态农业开发有限公司 | 一种西柚汁饮品的配方及其制备方法 |
CN105077438A (zh) * | 2015-08-14 | 2015-11-25 | 沈凯 | 一种西柚汁保健饮品 |
-
2016
- 2016-03-25 CN CN201610174489.3A patent/CN105661210A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101467755A (zh) * | 2007-12-27 | 2009-07-01 | 天津市中英保健食品有限公司 | 浓缩天然西柚汁 |
CN102440414A (zh) * | 2010-10-13 | 2012-05-09 | 段英侠 | 一种蜂蜜柚子汁 |
CN103099260A (zh) * | 2011-11-11 | 2013-05-15 | 威海金琳水产有限公司 | 桑葚葡萄柚混合饮料及制作方法 |
CN103844291A (zh) * | 2012-11-30 | 2014-06-11 | 邓耀林 | 沙田柚汁及其制备方法 |
CN103932324A (zh) * | 2014-04-04 | 2014-07-23 | 郎溪县侯村大千生态农业开发有限公司 | 一种西柚汁饮品的配方及其制备方法 |
CN105077438A (zh) * | 2015-08-14 | 2015-11-25 | 沈凯 | 一种西柚汁保健饮品 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115119911A (zh) * | 2022-06-06 | 2022-09-30 | 河南英的食品有限公司 | 一种含红西柚的复合果汁及加工方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106173772A (zh) | 一种蔬果酵素固体饮料及其制备方法 | |
CN103609766B (zh) | 一种具有修身美容养颜功能的泡袋剂 | |
CN105167037A (zh) | 一种具有补血养颜功效的姜汁饮料及其制备方法 | |
CN107242505A (zh) | 一种具有美容养颜功效的保健蜂蜜及其制备方法 | |
CN102048225B (zh) | 一种具有改善生长发育功能的红枣保健饮料 | |
CN102845795A (zh) | 一种功能性保健饮料 | |
CN110583780A (zh) | 一种可以预防和降低高血压和高尿酸的固体饮料 | |
CN105768082A (zh) | 一种营养保健药膳粉 | |
CN103251057A (zh) | 一种滋补养颜的药膳羹 | |
CN103519267A (zh) | 一种蜂蜜醋保健饮料及其制作方法 | |
CN107927506A (zh) | 一种高效抗氧化的多酚型饮料 | |
CN102048076A (zh) | 一种纯天然植物合成山药饮品 | |
CN101185706B (zh) | 具有延缓衰老作用的沙棘营养复合剂及其制备工艺 | |
CN105661210A (zh) | 一种混合味西柚汁 | |
CN111317081A (zh) | 一种具有美容养颜功能的饮料 | |
CN103798791A (zh) | 一种补气养血组合物 | |
CN107439854A (zh) | 一种具有保健功能的营养健康果蔬汁饮料及其制作方法 | |
CN106070808A (zh) | 一种复合饮料及制作方法 | |
CN106666534B (zh) | 一种儿童果蔬超微粉咀嚼片及其制备方法 | |
CN104256582A (zh) | 一种缓解女性更年期各种症状的保健品配方 | |
CN104187934A (zh) | 一种椰子葡萄汁及其制备方法 | |
CN107467596A (zh) | 一种美容养颜的保健蜂蜜及其制备方法 | |
CN107439856A (zh) | 一种具有保健功能的营养健康果蔬汁饮料及其制作方法 | |
CN107259530A (zh) | 一种用于安神、改善睡眠的百香果配方食品 | |
CN107213377A (zh) | 一种金钗石斛美容汤剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160615 |
|
RJ01 | Rejection of invention patent application after publication |